These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12192156)

  • 1. Biomimetic oxidation of 2-methylimidazole derivative with a chemical model system for cytochrome P-450.
    Miyachi H; Nagatsu Y
    Chem Pharm Bull (Tokyo); 2002 Aug; 50(8):1137-40. PubMed ID: 12192156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative metabolism of 5-o-caffeoylquinic acid (chlorogenic acid), a bioactive natural product, by metalloporphyrin and rat liver mitochondria.
    dos Santos MD; Martins PR; dos Santos PA; Bortocan R; Iamamoto Y; Lopes NP
    Eur J Pharm Sci; 2005 Sep; 26(1):62-70. PubMed ID: 16019193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloporphyrins as biomimetic models for cytochrome p-450 in the oxidation of atrazine.
    Gotardo MC; Moraes LA; Assis MD
    J Agric Food Chem; 2006 Dec; 54(26):10011-8. PubMed ID: 17177535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention mechanism of imidazoles in connective tissue. III. Aldehyde adduct formation of a 4(5H)(or5(4H))-imidazolone product in vitro.
    Ohta K; Fukasawa Y; Yamaguchi J; Akimoto M; Kohno Y; Fukushima K; Suwa T; Awazu S
    Biol Pharm Bull; 1998 Sep; 21(9):958-63. PubMed ID: 9781847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of imidazole, 1-methylimidazole and 4-nitroimidazole to yeast cytochrome c peroxidase (CcP) and the distal histidine mutant, CcP(H52L).
    Erman JE; Chinchilla D; Studer J; Vitello LB
    Biochim Biophys Acta; 2015 Aug; 1854(8):869-81. PubMed ID: 25907133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomimetic modeling of oxidative drug metabolism : Strategies, advantages and limitations.
    Lohmann W; Karst U
    Anal Bioanal Chem; 2008 May; 391(1):79-96. PubMed ID: 18163163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomimetic alcohol oxidations by an iron(III) porphyrin complex: relevance to cytochrome P-450 catalytic oxidation and involvement of the two-state radical rebound mechanism.
    Han JH; Yoo SK; Seo JS; Hong SJ; Kim SK; Kim C
    Dalton Trans; 2005 Jan; (2):402-6. PubMed ID: 15616733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomimetic in vitro oxidation of lapachol: a model to predict and analyse the in vivo phase I metabolism of bioactive compounds.
    Niehues M; Barros VP; Emery Fda S; Dias-Baruffi M; Assis Md; Lopes NP
    Eur J Med Chem; 2012 Aug; 54():804-12. PubMed ID: 22796040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regio- and diastereocontrolled preparative oxidation of methyloctalones by a biomimetic porphyrin catalyst.
    Akagah B; Estour F; Vérité P; Lameiras P; Nour M; Cavé C; Ménager S; Lafont O
    Chirality; 2004 Jul; 16(6):398-403. PubMed ID: 15190585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramolecular hydrogen bonding as a determinant of the inhibitory potency of N-unsubstituted imidazole derivatives towards mammalian hemoproteins.
    Perrin L; André F; Aninat C; Ricoux R; Mahy JP; Shangguan N; Joullié MM; Delaforge M
    Metallomics; 2009 Mar; 1(2):148-56. PubMed ID: 21305108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation.
    Islam SA; Wolf CR; Lennard MS; Sternberg MJ
    Carcinogenesis; 1991 Dec; 12(12):2211-9. PubMed ID: 1747920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen atom transfer reactions of iron-porphyrin-imidazole complexes as models for histidine-ligated heme reactivity.
    Warren JJ; Mayer JM
    J Am Chem Soc; 2008 Mar; 130(9):2774-6. PubMed ID: 18257574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partially and fully beta-brominated Mn-porphyrins in P450 biomimetic systems: effects of the degree of bromination on electrochemical and catalytic properties.
    do Nascimento E; de F Silva G; Caetano FA; Fernandes MA; da Silva DC; de Carvalho ME; Pernaut JM; Rebouças JS; Idemori YM
    J Inorg Biochem; 2005 May; 99(5):1193-204. PubMed ID: 15833343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.
    Stearns RA; Chakravarty PK; Chen R; Chiu SH
    Drug Metab Dispos; 1995 Feb; 23(2):207-15. PubMed ID: 7736913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of imidazole- and 2-methyl imidazole-containing farnesyl-protein transferase inhibitors: interaction with and metabolism by rat hepatic cytochrome P450s.
    Tang C; Chiba M; Nishime J; Hochman JH; Chen I; Williams TM; Lin JH
    Drug Metab Dispos; 2000 Jun; 28(6):680-6. PubMed ID: 10820141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicry of phase I drug metabolism--novel methods for metabolite characterization and synthesis.
    Johansson T; Weidolf L; Jurva U
    Rapid Commun Mass Spectrom; 2007; 21(14):2323-31. PubMed ID: 17575570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regioselective biomimetic oxidation of etodolac with iodosylbenzene catalyzed by halogenated and perhalogenated metalloporphyrins in dichloromethane.
    Chauhan SM; Kandadai SA; Sahoo B
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1375-6. PubMed ID: 11605677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aflatoxin B1 activation to a plasmid mutagen by a chemical model of cytochrome P-450.
    Wood ML; Smith JR; Garner RC
    Mutat Res; 1987 Jan; 176(1):11-20. PubMed ID: 3099185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative aromatization of 1,4-dihydropyridines and pyrazolines using HbA-H(2)O(2): An efficient biomimetic catalyst system providing metabolites of drug candidates.
    Kumar A; Maurya RA; Sharma S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4432-6. PubMed ID: 19497741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.